(A) We provide 2 dosages of
Paclitaxel Injection:
Origin: EU – it is
manufactured in European cGMP oncology factory with
guaranteed high quality.
30mg/5ml vials.
100mg/16.7ml vials.
The production plan is
200,000 vials in 2003. It can be increased according the market demanding.
Prompt delivery once the
exclusive agent contract is signed.
Targeting Market: Europe and
global market.
(B) 21CEC is in charge of the
marketing and selecting the exclusive agents for this product.
We will take a potential
exclusive agent in each country for its distribution. This exclusive agent must
have the potential capability to occupy 20-25% market share of Paclitaxel
Injection in their own country.
(C) We will provide the registration
dossier for the exclusive agent to do registration in their own
country.
(D) The wholesale price can be
varied according each country’s situation based on mutual benefits.
The payment term
is L/C at sight – purchase plan should be on an annual basis to secure the
supply.
Once the exclusive
agent is selected, a contract will be signed.
Contact person:
Dr. C. Bleasdale
CEO, 21CEC PX Pharm Ltd
Direct Tel line: +44 7732
971307
Fax: +44 1323 763517
E
mail: <21cec@21cep.com>
21CEC & 21CEP (UK & USA)
21CEC PX PHARM LTD (UK)
Head Office:
45
Oaklands, Westham, Pevensey, East Sussex BN24 5AW, UK
Tel: (44) 01323
763517 &
(44) 07732 971307 (CEO Direct line )
Fax: (44) 1323
763517 (UK) &
(1) 323 8439307 (USA)
(1) 509 7524767
(USA)
E mail: <21cec@21cep.com>, < 21cec@21cec.com>
URL: http://www.21cec.com/
http://www.21cep.com/ (USA)
http://www.21cecPharm.com/
(USA)